175 related articles for article (PubMed ID: 25125483)
1. Iatrogenic parkinsonism: the role of flunarizine and cinnarizine.
Miguel R; Correia AS; Bugalho P
J Parkinsons Dis; 2014; 4(4):645-9. PubMed ID: 25125483
[TBL] [Abstract][Full Text] [Related]
2. Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility.
Negrotti A; Calzetti S; Sasso E
Neurotoxicology; 1992; 13(1):261-4. PubMed ID: 1508427
[TBL] [Abstract][Full Text] [Related]
3. Flunarizine and cinnarizine-induced parkinsonism: 25 years of de Melo-Souza's syndrome.
Teive HA; Munhoz RP; Ferraz HB
Arq Neuropsiquiatr; 2009 Sep; 67(3B):957. PubMed ID: 19838540
[No Abstract] [Full Text] [Related]
4. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis.
Teive HA; Troiano AR; Germiniani FM; Werneck LC
Parkinsonism Relat Disord; 2004 Jun; 10(4):243-5. PubMed ID: 15120099
[TBL] [Abstract][Full Text] [Related]
5. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism.
Negrotti A; Calzetti S
Mov Disord; 1997 Jan; 12(1):107-10. PubMed ID: 8990063
[TBL] [Abstract][Full Text] [Related]
6. Permanent non-progressive cinnarizine and flunarizine-induced parkinsonism: An under-recognized tardive syndrome in the elderly?
Calzetti S; Negrotti A
J Neurol Sci; 2023 Jan; 444():120526. PubMed ID: 36584558
[TBL] [Abstract][Full Text] [Related]
7. Parkinsonism and other movement disorders in outpatients in chronic use of cinnarizine and flunarizine.
Fabiani G; Pastro PC; Froehner C
Arq Neuropsiquiatr; 2004 Sep; 62(3B):784-8. PubMed ID: 15476069
[TBL] [Abstract][Full Text] [Related]
8. Risk of parkinsonism induced by flunarizine or cinnarizine: a population-based study.
Lin HL; Lin HC; Tseng YF; Chen SC; Hsu CY
Eur J Clin Pharmacol; 2017 Mar; 73(3):365-371. PubMed ID: 27986997
[TBL] [Abstract][Full Text] [Related]
9. Extrapyramidal symptoms associated with calcium-channel blockers.
Daniel JR; Mauro VF
Ann Pharmacother; 1995 Jan; 29(1):73-5. PubMed ID: 7711350
[TBL] [Abstract][Full Text] [Related]
10. Flunarizine- and cinnarizine-induced extrapyramidal reactions.
Micheli F; Pardal MF; Gatto M; Torres M; Paradiso G; Parera IC; Giannaula R
Neurology; 1987 May; 37(5):881-4. PubMed ID: 3574697
[TBL] [Abstract][Full Text] [Related]
11. Movement disorders and depression due to flunarizine and cinnarizine.
Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J
Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706
[TBL] [Abstract][Full Text] [Related]
12. [Drug-induced parkinsonism. Clinical aspects compared with Parkinson disease].
Errea-Abad JM; Ara-Callizo JR; Aibar-Remón C
Rev Neurol; 1998 Jul; 27(155):35-9. PubMed ID: 9674021
[TBL] [Abstract][Full Text] [Related]
13. Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine.
Jhang KM; Huang JY; Nfor ON; Tung YC; Ku WY; Lee CT; Liaw YP
Eur J Clin Pharmacol; 2017 Jul; 73(7):911-916. PubMed ID: 28386684
[TBL] [Abstract][Full Text] [Related]
14. Etiology of parkinsonism in a Brazilian movement disorders clinic.
Cardoso F; Camargos ST; Silva Júnior GA
Arq Neuropsiquiatr; 1998 Jun; 56(2):171-5. PubMed ID: 9698723
[TBL] [Abstract][Full Text] [Related]
15. D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects. A SPECT study.
Brücke T; Wöber C; Podreka I; Wöber-Bingöl C; Asenbaum S; Aull S; Wenger S; Ilieva D; Harasko-van der Meer C; Wessely P
J Cereb Blood Flow Metab; 1995 May; 15(3):513-8. PubMed ID: 7714010
[TBL] [Abstract][Full Text] [Related]
16. Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine.
Capellà D; Laporte JR; Castel JM; Tristán C; Cos A; Morales-Olivas FJ
BMJ; 1988 Sep; 297(6650):722-3. PubMed ID: 3147743
[No Abstract] [Full Text] [Related]
17. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
[TBL] [Abstract][Full Text] [Related]
18. Tremor analysis separates Parkinson's disease and dopamine receptor blockers induced parkinsonism.
Shaikh AG
Neurol Sci; 2017 May; 38(5):855-863. PubMed ID: 28229302
[TBL] [Abstract][Full Text] [Related]
19. The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics.
Munhoz RP; Werneck LC; Teive HA
Clin Neurol Neurosurg; 2010 Jun; 112(5):431-5. PubMed ID: 20347518
[TBL] [Abstract][Full Text] [Related]
20. Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
Munhoz RP; Bertucci Filho D; Teive HA
Neurol Sci; 2017 Feb; 38(2):319-324. PubMed ID: 27853909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
